Developer docs
API playgroundTry for free, no card

Search company profiles

Tau Ventures

Full company profile

uuid0002ie5

Namestring
Tau Ventures
Legal namestring
Tau Ventures
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Tau Ventures is a Palo Alto-based early-stage venture capital fund founded in 2019 by Amit Garg. The firm invests across pre-seed, seed, and growth stages in companies developing AI-driven technologies, with stated vertical focus on healthcare, enterprise software, and automation (including autonomous robotics). As of its 2025 Year in Review the firm reported approximately $93M in assets under management and supported roughly 80 portfolio companies. The team's operating pedigree spans Google, Samsung NEXT Ventures, Norwest Ventures, Microsoft, McKinsey, Citigroup Strategic Investment, Novartis, and Chan Zuckerberg Biohub, and the firm maintains a 5,000+ operator and founder network that it activates for portfolio company go-to-market support, hiring introductions, and PR amplification.

Tau Ventures runs three stage-based programs (Pre-Seed, Seed, Growth) backed by a curated advisor bench of 100+ executives from Tesla, Lucid, Stanford, Harvard Medical School, Mass General, Pfizer, J&J, Anthropic, Meta, Apple, Google, and others. Its distribution and deal-flow engine is relationship-driven: founder dinners, the annual Tau Day gathering (200+ attendees, 8 portfolio companies presenting in January 2026), and warm introductions through the operator network. Geographic reach extends beyond Palo Alto headquarters to DC, NYC, LA, and SF.

The fund's economics are standard venture capital: management fees on AUM plus carried interest on exits. Realized liquidity to date includes the Netskope IPO at $8.6B, the Oak St. Health M&A at $10.6B, and the AbSci IPO at $2.1B, plus acquisitions of 1Password, Armorblox, RubiconMD, and others. Pending liquidity includes the projected XTEND NASDAQ listing at approximately $1.5B (expected to deliver ~$25M in returns on a $2M original investment). No explicit revenue, fee, or carry figure is publicly disclosed.

Short descriptiontext

Tau Ventures is a Palo Alto-based, AI-first early-stage venture capital fund founded in 2019 that backs approximately 80 companies across healthcare, enterprise, and automation, deploying capital from pre-seed through growth and supporting founders via a 5,000+ operator network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital fund, early stage investing, AI startup funding, healthcare AI investing, operator-led investing
Industry1 code
1Accelerators & Incubators (Investor-Operated)
CodeFSANAAAMPrimaryYes
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Venture fund management & carry
TypeSubscription Recurring
Description

Early-stage venture capital fund economics — management fees on assets under management (reported at $93M in 2025 Year in Review) plus future carried interest on exits from 80 portfolio companies spanning pre-seed to growth. Multiple successful IPOs (AbSci, Netskope) and acquisitions (1Password, Armorblox, Dasera, RubiconMD, RapidDeploy, Augmend, PassageID, Pronto, Glidian, Vidoso, Totient, Hank, Oak St. Health M&A $10.6B) drive realized returns.

tauventures.com
2Realized returns from portfolio exits
TypeOne Time License
Description

Realized investment returns from successful portfolio exits — e.g., XTEND expected IPO at ~$1.5B valuation projected to deliver Tau Ventures approximately $25 million in returns, more than 10x its original $2 million investment.

jpost.com
Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Tau Ventures is an early-stage venture capital fund that provides capital and operator support to AI-driven startups in healthcare, enterprise, and automation, deploying investments from pre-seed through growth stages across approximately 80 portfolio companies. The fund pairs financial capital with hands-on operating expertise and a 5,000+ founder/operator network to accelerate go-to-market, hiring, and PR for portfolio companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 5,000+ operator/founder network activated for portfolio GTM
+6 more records
Product overview1 text field

Tau Ventures is a Palo Alto-based early-stage venture capital fund (established 2019) that partners with founders building AI-driven technologies across healthcare, enterprise, and automation. Its offering is structured as a single venture fund with stage-based programs (Pre-Seed, Seed, and Growth) that support approximately 80 portfolio companies from initial idea through scaling, providing capital, operating expertise, and an extensive advisor network. The fund does not itself market a software product; rather, it backs portfolio companies (such as Understood Care, Statisfy, Viven, Infinitus, Tofu, OpenInfer, Klinic, Vidoso.ai, Oath Surgical, Tonic, Autonomize AI, Alpaca Health, ShiftRx, Vecna Robotics, Olli Health, Teiko, Flo Recruit, Labelbox, Beaming Health, AmplifyMD, Sami, Distribute, ArmorCode, Assort Health, Siftwell, Cerby, and others) that constitute its portfolio of supported ventures.

Product and service1 record
1Tau Ventures Fund
CategoryVenture Capital Investment
Description

Early-stage venture capital fund deploying capital across Pre-Seed, Seed, and Growth stages to AI-driven startups in healthcare, enterprise, and automation, paired with operator mentorship, hiring support, GTM introductions, and access to a 5,000+ founder/advisor network. Aimed at venture-backed founders and their companies from initial prototype through scaling.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCore InfrastructureTypeOthersAnnounced on2024-01-01
Description

Tau maintains a 100+ advisor network including operators from Tesla (Marc Tarpenning, co-founder), Lucid Motors (Peter Rawlinson, CTO), Color Health (Othman Laraki), SambaNova (Kunle Olukotun), Capital One (Prem Natarajan), Workday, Microsoft, Samsung Electronics, Stanford University, Harvard Business School, Boston University, Mass General Hospital, Mount Sinai, Pfizer, J&J, Bristol-Myers Squibb, Quest Diagnostics, GE Healthcare, Anthropic, Meta, Apple, Google, plus venture partners from Norwest Ventures (Sergio Monsalve) and KPMG (Vijay Jajoo).

Strategic tierFoundational RelationshipTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Per JPost reporting, TAU Ventures is described as 'Tel Aviv University's early-stage venture capital fund' — implying an institutional relationship with the university ecosystem, likely for sourcing deals, talent, and research collaborations.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Boston-based early-stage venture fund focused exclusively on healthcare technology, including digital health and AI-enabled care. Most directly comparable to Tau given similar stage focus, healthcare AI specialization, and frequent co-investment with Tau (Keebler Health, Cascala Health).

TypeBroad incumbent
Description

Mega-fund with a dedicated a16z Bio/Health vertical investing in digital health and AI-enabled therapeutics/diagnostics at early stages. Comparable to Tau through AI-first healthcare thesis but at materially larger AUM scale (multi-billion fund).

TypeBroad incumbent
Description

Early-stage venture firm investing in frontier science, healthcare, and AI (including defense/dual-use). Comparable to Tau through AI-first investing across enterprise, healthcare, and automation verticals including companies like XTEND that overlap with Tau's portfolio.

TypeBroad incumbent
Description

Multi-stage venture firm with long-standing healthcare and AI/cloud franchises. Comparable to Tau through early-stage enterprise and healthcare AI investing and a multi-stage approach (pre-seed through growth), but at materially larger AUM and broader LP base.

TypeBroad incumbent
Description

Multi-stage venture firm with a dedicated Health Assurance thesis that has built strategic partnerships with health systems (HCA, Penn Medicine). Comparable to Tau through early-stage healthcare AI investing and a founder-support operating model, but at vastly greater scale and with health-system LP distribution.

TypeDirect peer
Description

Operator-led venture firm investing in AI-first enterprise, healthcare, and logistics startups. Comparable to Tau through similar operator-first thesis, AI specialization, and stage focus, with overlapping portfolio categories in enterprise AI infrastructure.

TypeBroad incumbent
Description

Large venture firm with deep AI and healthcare investing franchises, founded by Vinod Khosla. Comparable to Tau through early-stage AI-first investing across enterprise and healthcare verticals but at substantially larger AUM.

TypeDirect peer
Description

Seed-stage venture firm focused on AI-first enterprise and healthcare startups. Co-led Cascala Health's seed round with Tau, making it a directly comparable early-stage AI healthcare investor at similar fund vintage and size.

TypeDirect peer
Description

Healthcare-exclusive growth equity and venture firm investing in technology-enabled healthcare companies. Co-led Alaffia Health's $55M Series B alongside Tau, providing a directly comparable peer with similar healthcare AI focus and stage.

TypeDirect peer
Description

Silicon Valley seed and early-stage venture firm with healthcare AI and enterprise AI theses. Comparable to Tau through stage, geographic focus (Bay Area), and AI-first investing approach across similar verticals.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers36 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment125 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tau Ventures

Venture Capitaltauventures.com

Tau Ventures is a Palo Alto-based, AI-first early-stage venture capital fund founded in 2019 that backs approximately 80 companies across healthcare, enterprise, and automation, deploying capital from pre-seed through growth and supporting founders via a 5,000+ operator network.

What Tau Ventures does

Tau Ventures is a Palo Alto-based early-stage venture capital fund founded in 2019 by Amit Garg. The firm invests across pre-seed, seed, and growth stages in companies developing AI-driven technologies, with stated vertical focus on healthcare, enterprise software, and automation (including autonomous robotics). As of its 2025 Year in Review the firm reported approximately $93M in assets under management and supported roughly 80 portfolio companies. The team's operating pedigree spans Google, Samsung NEXT Ventures, Norwest Ventures, Microsoft, McKinsey, Citigroup Strategic Investment, Novartis, and Chan Zuckerberg Biohub, and the firm maintains a 5,000+ operator and founder network that it activates for portfolio company go-to-market support, hiring introductions, and PR amplification.

Tau Ventures runs three stage-based programs (Pre-Seed, Seed, Growth) backed by a curated advisor bench of 100+ executives from Tesla, Lucid, Stanford, Harvard Medical School, Mass General, Pfizer, J&J, Anthropic, Meta, Apple, Google, and others. Its distribution and deal-flow engine is relationship-driven: founder dinners, the annual Tau Day gathering (200+ attendees, 8 portfolio companies presenting in January 2026), and warm introductions through the operator network. Geographic reach extends beyond Palo Alto headquarters to DC, NYC, LA, and SF.

The fund's economics are standard venture capital: management fees on AUM plus carried interest on exits. Realized liquidity to date includes the Netskope IPO at $8.6B, the Oak St. Health M&A at $10.6B, and the AbSci IPO at $2.1B, plus acquisitions of 1Password, Armorblox, RubiconMD, and others. Pending liquidity includes the projected XTEND NASDAQ listing at approximately $1.5B (expected to deliver ~$25M in returns on a $2M original investment). No explicit revenue, fee, or carry figure is publicly disclosed.

Tau Ventures firmographics

Firmographics
Name
Tau Ventures
Legal name
Tau Ventures
Website
http://www.tauventures.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Tau Ventures is a Palo Alto-based, AI-first early-stage venture capital fund founded in 2019 that backs approximately 80 companies across healthcare, enterprise, and automation, deploying capital from pre-seed through growth and supporting founders via a 5,000+ operator network.
Ownership category
akta.pro rank

Tau Ventures industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro primary industry
Accelerators & Incubators (Investor-Operated) (FSANAAAM)

Keywords

  • Venture capital fund
  • Early stage investing
  • AI startup funding
  • Healthcare AI investing
  • Operator-led investing

Where Tau Ventures is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Tau Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Venture fund management & carry: Early-stage venture capital fund economics — management fees on assets under management (reported at $93M in 2025 Year in Review) plus future carried interest on exits from 80 portfolio companies spanning pre-seed to growth. Multiple successful IPOs (AbSci, Netskope) and acquisitions (1Password, Armorblox, Dasera, RubiconMD, RapidDeploy, Augmend, PassageID, Pronto, Glidian, Vidoso, Totient, Hank, Oak St. Health M&A $10.6B) drive realized returns.
  2. Realized returns from portfolio exits: Realized investment returns from successful portfolio exits — e.g., XTEND expected IPO at ~$1.5B valuation projected to deliver Tau Ventures approximately $25 million in returns, more than 10x its original $2 million investment.

Go-to-market motion1 record

Distribution channels5 records

Tau Ventures product offering

Product offering

Core offering

Tau Ventures is an early-stage venture capital fund that provides capital and operator support to AI-driven startups in healthcare, enterprise, and automation, deploying investments from pre-seed through growth stages across approximately 80 portfolio companies. The fund pairs financial capital with hands-on operating expertise and a 5,000+ founder/operator network to accelerate go-to-market, hiring, and PR for portfolio companies.

Product overview

Tau Ventures is a Palo Alto-based early-stage venture capital fund (established 2019) that partners with founders building AI-driven technologies across healthcare, enterprise, and automation. Its offering is structured as a single venture fund with stage-based programs (Pre-Seed, Seed, and Growth) that support approximately 80 portfolio companies from initial idea through scaling, providing capital, operating expertise, and an extensive advisor network. The fund does not itself market a software product; rather, it backs portfolio companies (such as Understood Care, Statisfy, Viven, Infinitus, Tofu, OpenInfer, Klinic, Vidoso.ai, Oath Surgical, Tonic, Autonomize AI, Alpaca Health, ShiftRx, Vecna Robotics, Olli Health, Teiko, Flo Recruit, Labelbox, Beaming Health, AmplifyMD, Sami, Distribute, ArmorCode, Assort Health, Siftwell, Cerby, and others) that constitute its portfolio of supported ventures.

Differentiator

Problem solved

Functional benefit

Products and services

  • Tau Ventures Fund Early-stage venture capital fund deploying capital across Pre-Seed, Seed, and Growth stages to AI-driven startups in healthcare, enterprise, and automation, paired with operator mentorship, hiring support, GTM introductions, and access to a 5,000+ founder/advisor network. Aimed at venture-backed founders and their companies from initial prototype through scaling.

Quantifiable outcome

  • 5,000+ operator/founder network activated for portfolio GTM
  • +6 more outcomes

Companies that use Tau Ventures

Customer profile

Named customers36 records

Ideal customer profiles1 record

Tau Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Tau Ventures partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core infrastructure and foundational relationship.

  • Advisor Network (100+ executives)core infrastructureOthers · 1 January 2024Tau maintains a 100+ advisor network including operators from Tesla (Marc Tarpenning, co-founder), Lucid Motors (Peter Rawlinson, CTO), Color Health (Othman Laraki), SambaNova (Kunle Olukotun), Capital One (Prem Natarajan), Workday, Microsoft, Samsung Electronics, Stanford University, Harvard Business School, Boston University, Mass General Hospital, Mount Sinai, Pfizer, J&J, Bristol-Myers Squibb, Quest Diagnostics, GE Healthcare, Anthropic, Meta, Apple, Google, plus venture partners from Norwest Ventures (Sergio Monsalve) and KPMG (Vijay Jajoo).
  • Tel Aviv Universityfoundational relationshipStrategic or Co-development Partner · 1 January 2019Per JPost reporting, TAU Ventures is described as 'Tel Aviv University's early-stage venture capital fund' — implying an institutional relationship with the university ecosystem, likely for sourcing deals, talent, and research collaborations.

Scale indicators11 records

Recent moves7 records

Expansion highlights5 records

Tau Ventures competitors and assessment

Company assessment

Direct peers

  • Flare Capital Partners: Boston-based early-stage venture fund focused exclusively on healthcare technology, including digital health and AI-enabled care. Most directly comparable to Tau given similar stage focus, healthcare AI specialization, and frequent co-investment with Tau (Keebler Health, Cascala Health).
  • 8VC: Operator-led venture firm investing in AI-first enterprise, healthcare, and logistics startups. Comparable to Tau through similar operator-first thesis, AI specialization, and stage focus, with overlapping portfolio categories in enterprise AI infrastructure.
  • Eniac Ventures: Seed-stage venture firm focused on AI-first enterprise and healthcare startups. Co-led Cascala Health's seed round with Tau, making it a directly comparable early-stage AI healthcare investor at similar fund vintage and size.
  • Transformation Capital: Healthcare-exclusive growth equity and venture firm investing in technology-enabled healthcare companies. Co-led Alaffia Health's $55M Series B alongside Tau, providing a directly comparable peer with similar healthcare AI focus and stage.
  • Maverick Ventures: Silicon Valley seed and early-stage venture firm with healthcare AI and enterprise AI theses. Comparable to Tau through stage, geographic focus (Bay Area), and AI-first investing approach across similar verticals.

Broad incumbents

  • Andreessen Horowitz (a16z Bio/Health): Mega-fund with a dedicated a16z Bio/Health vertical investing in digital health and AI-enabled therapeutics/diagnostics at early stages. Comparable to Tau through AI-first healthcare thesis but at materially larger AUM scale (multi-billion fund).
  • Lux Capital: Early-stage venture firm investing in frontier science, healthcare, and AI (including defense/dual-use). Comparable to Tau through AI-first investing across enterprise, healthcare, and automation verticals including companies like XTEND that overlap with Tau's portfolio.
  • Bessemer Venture Partners: Multi-stage venture firm with long-standing healthcare and AI/cloud franchises. Comparable to Tau through early-stage enterprise and healthcare AI investing and a multi-stage approach (pre-seed through growth), but at materially larger AUM and broader LP base.
  • General Catalyst: Multi-stage venture firm with a dedicated Health Assurance thesis that has built strategic partnerships with health systems (HCA, Penn Medicine). Comparable to Tau through early-stage healthcare AI investing and a founder-support operating model, but at vastly greater scale and with health-system LP distribution.
  • Khosla Ventures: Large venture firm with deep AI and healthcare investing franchises, founded by Vinod Khosla. Comparable to Tau through early-stage AI-first investing across enterprise and healthcare verticals but at substantially larger AUM.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Tau Ventures social profiles

Digital presence

Tau Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tau Ventures leadership team

Management profile

Number of profiles

Profiles9 records

Tau Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tau Ventures M&A and investment

M&A and investment

M&A

Investments125 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tau Ventures

What does Tau Ventures do?

Tau Ventures is an early-stage venture capital fund that provides capital and operator support to AI-driven startups in healthcare, enterprise, and automation, deploying investments from pre-seed through growth stages across approximately 80 portfolio companies. The fund pairs financial capital with hands-on operating expertise and a 5,000+ founder/operator network to accelerate go-to-market, hiring, and PR for portfolio companies.

Is Tau Ventures a public or private company?

Tau Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Tau Ventures founded?

Tau Ventures was founded in 2019. It employs 1 to 10 people.

Where is Tau Ventures based?

Tau Ventures is headquartered in Palo Alto, United States, in the North America region.

How does Tau Ventures make money?

Two revenue lines are on record. Venture fund management & carry is the primary driver. The others are realized returns from portfolio exits.

Who are Tau Ventures's main competitors?

Direct peers on record are Flare Capital Partners, 8VC, Eniac Ventures, Transformation Capital and Maverick Ventures. Broad incumbents are Andreessen Horowitz (a16z Bio/Health), Lux Capital, Bessemer Venture Partners, General Catalyst and Khosla Ventures.

Does Tau Ventures have an API?

No public API is recorded for Tau Ventures.

What industry is Tau Ventures in?

Tau Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarKairon Health Raises $5 Million to Power AI-Driven Execution in Value-Based CareKairon Health raised $5 million in venture funding led by Flare Capital Partners to fund AI development and expansion. The company's platform serves ACOs and health systems, covering over 1 million attributed lives across 30+ states. The capital aims to support Medicare's upcoming LEAD model and increased provider risk.WebrazziAssort Health, 1.2 milyar dolar değerleme üzerinden 120 milyon dolar yatırım aldıAssort Health raised $120 million in a Series C round at a $1.2 billion valuation, led by Menlo Ventures. The AI-powered remote healthcare platform will use the funds to scale its AI-driven operations system and expand patient access. The company's platform has interacted with over 190 million patients.Venture Capital Access OnlineAssort Health Raises $120 Million Series C to Scale Largest Deployment of AI Agents for the Patient JourneyAssort Health raised $120 million in a Series C led by Menlo Ventures at a $1.2 billion valuation. The company has raised over $222 million and reports 190 million patient interactions and 20x revenue growth in 15 months. It is expanding into health system operations.Morningstar/C O R R E C T I O N — Assort Health/Assort Health raised $120 million in a Series C led by Menlo Ventures at a $1.2 billion valuation. The company has now raised over $222 million and reports 190 million patient interactions and 20x revenue growth in 15 months. It plans to expand into health system operations.BhbusinessKlinic Raises $24M for Behavioral Health, Speciality Provider Enablement PlatformKlinic, a Frisco-based digital healthcare platform, raised $24 million in a funding round. The company, founded in 2021, offers enablement tools for specialty providers and has secured backing from 34 investors, including Tau Ventures and Upstream Ventures. The use of funds and participating firms were not disclosed.The SaaS NewsKeebler Health Secures $16M Series AKeebler Health, a Durham-based health technology company, raised $16 million in Series A funding led by Flare Capital Partners, bringing total funding to $23 million. The company will use the funds to accelerate commercial growth, expand its team, and scale infrastructure for value-based care organizations.Venture Capital Access OnlineKeebler Health Raises $16M to Unlock Unstructured Clinical Data for the Next Generation of Risk Adjustment, Population Health, and RADV Audit ReadinessKeebler Health raised $16 million in a Series A round led by Flare Capital Partners, bringing total funding to $23 million. The LLM-native platform surfaces missed HCC coding from unstructured clinical notes, addressing the fact that 80% of healthcare information is unstructured. The funding will support commercial growth and expansion into adjacent use cases like RADV audit readiness.FinSMEsKeebler Health Raises $16M in Series A FundingKeebler Health raised $16M in Series A funding led by Flare Capital Partners. The Durham, NC-based LLM-native health technology company will use the funds for commercial growth, team expansion, and infrastructure to serve value-based care organizations. Its platform processes unstructured clinical documentation to surface missed HCC coding opportunities.The Times of IndiaBuilding the AI-First Future: Inside Tau Ventures with Amit Garg - The Times of IndiaTau Ventures, an AI-first venture capital fund founded by Amit Garg and Sanjay Rao in 2019, manages $93 million across three funds and has invested in early-stage AI companies including Assort, Labelbox, and Iterative. The firm follows a 'n plus 1' investment strategy, concentrating follow-on capital in portfolio companies that achieve 10x or greater returns, with 98% of its portfolio companies successfully raising subsequent funding rounds. Healthcare has emerged as the top industry for AI adoption according to Garg, and the firm has built a community of over 5,000 investors on its mailing list to support portfolio companies.VC News DailyUptiq.ai Inks $12M Funding RoundUptiq.ai, an AI infrastructure provider for financial services, announced it has raised $12 million in a new funding round led by Silverton Partners, with participation from Live Oak Venture Partners, Tau Ventures, First Capital, and Green Visor Capital. The Dallas-based company builds AI platforms that enable financial institutions to modernize operations with intelligent automation for compliance, scalability, and speed. More than 140 institutions globally currently rely on Uptiq's platforms.